ICCM
Icecure Medical Ltd

2,942
Mkt Cap
$48.77M
Volume
575,215.00
52W High
$1.66
52W Low
$0.5341
PE Ratio
-2.58
ICCM Fundamentals
Price
$0.71
Prev Close
$0.7468
Open
$0.722
50D MA
$0.9569
Beta
0.37
Avg. Volume
1.1M
EPS (Annual)
-$0.2954
P/B
14.69
Rev/Employee
$45,708.33
Loading...
Loading...
News
all
press releases
IceCure's ProSense Showcased at TME Fall Summit: "Take the Lead in Breast Cancer Care" Roundtable Highlighting Cryoablation Advances
IceCure's ProSense Showcased at TME Fall Summit: 'Take the Lead in Breast Cancer Care' Roundtable Highlighting Cryoablation Advances IceCure's ProSense Showcased at TME Fall Summit: 'Take the Lead in...
PR Newswire·18d ago
News Placeholder
More News
News Placeholder
IceCure Medical to Attend the 2025 Maxim Growth Summit
IceCure Medical to Attend the 2025 Maxim Growth Summit IceCure Medical to Attend the 2025 Maxim Growth Summit PR Newswire CAESAREA, Israel, Oct. 9, 2025 IceCure recently achieved a significant...
PR Newswire·22d ago
News Placeholder
ICCM Shares Rise as FDA Clears ProSense for Breast Cancer Treatment
IceCure Medical shares surge after FDA clears ProSense, marking the first minimally invasive breast cancer treatment for women aged 70 and above.
Zacks·25d ago
News Placeholder
IceCure Medical’s Treatment For Low-Risk Breast Cancer In Women Aged 70 And Over Receives FDA Approval
The company stated that the FDA has requested it conduct a post-market surveillance study to generate additional data.
Stocktwits·27d ago
News Placeholder
IceCure Medical Ltd. (ICCM) Q2 Earnings Surpass Estimates
IceCure Medical (ICCM) delivered earnings and revenue surprises of +200.00% and -34.38%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Viatris (VTRS) Tops Q2 Earnings and Revenue Estimates
Viatris (VTRS) delivered earnings and revenue surprises of +10.71% and +2.40%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Labcorp Holdings (LH) Q2 Earnings and Revenues Top Estimates
Labcorp (LH) delivered earnings and revenue surprises of +5.07% and +1.14%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Ascend Wellness Holdings, Inc. (AAWH) Reports Q1 Loss, Misses Revenue Estimates
Zacks·6mo ago
News Placeholder
IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense Cryoablation System in Israel
IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense Cryoablation System in Israel IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense Cryoablation...
PR Newswire·8mo ago
News Placeholder
IceCure's ProSense in the Spotlight at Society of Interventional Oncology (SIO) Annual Meeting: Award Winning Abstract and Hands-On Training for Breast Cryoablation as Medical Community Anticipates FDA's Market Authorization Decision
IceCure's ProSense in the Spotlight at Society of Interventional Oncology (SIO) Annual Meeting: Award Winning Abstract and Hands-On Training for Breast Cryoablation as Medical Community Anticipates...
PR Newswire·9mo ago

Latest ICCM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.